VISTN Stock Overview
Vistin Pharma ASA, through its subsidiary, Vistin Pharma AS, produces and sells active pharmaceutical ingredients (APIs) worldwide.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
Vistin Pharma ASA Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | kr23.50 |
| 52 Week High | kr25.10 |
| 52 Week Low | kr20.50 |
| Beta | 0.90 |
| 1 Month Change | 3.98% |
| 3 Month Change | -0.42% |
| 1 Year Change | 12.98% |
| 3 Year Change | -7.11% |
| 5 Year Change | 190.12% |
| Change since IPO | 24.34% |
Recent News & Updates
Recent updates
Would Vistin Pharma (OB:VISTN) Be Better Off With Less Debt?
Feb 23
A Look At The Fair Value Of Vistin Pharma ASA (OB:VISTN)
Sep 09Robust Earnings May Not Tell The Whole Story For Vistin Pharma (OB:VISTN)
Aug 25Investors In Vistin Pharma ASA (OB:VISTN) Should Consider This, First
Mar 15We're Keeping An Eye On Vistin Pharma's (OB:VISTN) Cash Burn Rate
Feb 20
Could The Vistin Pharma ASA (OB:VISTN) Ownership Structure Tell Us Something Useful?
Jan 29The Vistin Pharma (OB:VISTN) Share Price Is Up 119% And Shareholders Are Boasting About It
Jan 08Have Insiders Been Selling Vistin Pharma ASA (OB:VISTN) Shares?
Dec 16Is Vistin Pharma ASA (OB:VISTIN) At Risk Of Cutting Its Dividend?
Nov 26Shareholder Returns
| VISTN | NO Pharmaceuticals | NO Market | |
|---|---|---|---|
| 7D | -2.1% | 2.3% | 0.1% |
| 1Y | 13.0% | 7.5% | 4.6% |
Return vs Industry: VISTN exceeded the Norwegian Pharmaceuticals industry which returned 5.7% over the past year.
Return vs Market: VISTN exceeded the Norwegian Market which returned 2.9% over the past year.
Price Volatility
| VISTN volatility | |
|---|---|
| VISTN Average Weekly Movement | 3.9% |
| Pharmaceuticals Industry Average Movement | 4.8% |
| Market Average Movement | 5.2% |
| 10% most volatile stocks in NO Market | 10.5% |
| 10% least volatile stocks in NO Market | 3.0% |
Stable Share Price: VISTN has not had significant price volatility in the past 3 months.
Volatility Over Time: VISTN's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1969 | 78 | Magnus Tolleshaug | www.vistin.com |
Vistin Pharma ASA, through its subsidiary, Vistin Pharma AS, produces and sells active pharmaceutical ingredients (APIs) worldwide. It offers metformin HCl APIs and direct compressive granulates for the pharmaceutical industry. The company was founded in 1969 and is headquartered in Oslo, Norway.
Vistin Pharma ASA Fundamentals Summary
| VISTN fundamental statistics | |
|---|---|
| Market cap | kr1.04b |
| Earnings (TTM) | kr45.64m |
| Revenue (TTM) | kr438.33m |
22.8x
P/E Ratio2.4x
P/S RatioIs VISTN overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| VISTN income statement (TTM) | |
|---|---|
| Revenue | kr438.33m |
| Cost of Revenue | kr176.64m |
| Gross Profit | kr261.68m |
| Other Expenses | kr216.04m |
| Earnings | kr45.64m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Aug 23, 2024
| Earnings per share (EPS) | 1.03 |
| Gross Margin | 59.70% |
| Net Profit Margin | 10.41% |
| Debt/Equity Ratio | 0% |
How did VISTN perform over the long term?
See historical performance and comparisonDividends
4.3%
Current Dividend Yield97%
Payout RatioDoes VISTN pay a reliable dividends?
See VISTN dividend history and benchmarks| Vistin Pharma dividend dates | |
|---|---|
| Ex Dividend Date | Jun 05 2024 |
| Dividend Pay Date | Jun 18 2024 |
| Days until Ex dividend | 41 days |
| Days until Dividend pay date | 54 days |
Does VISTN pay a reliable dividends?
See VISTN dividend history and benchmarks